animal viral hepatitis: A hepatitis that involves viral infection of an animal causing inflammation of the liver.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
94 |
4. Check minimum number of eventsNone |
94 |
5. Include endpointsNone |
94 |
6. Filter based on genotype QC (FinnGen only) |
94 |
Control definitions (FinnGen only)
- Control exclude
- IBD_CMV
Extra metadata
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Cytomegaloviral hepatitis
based on the number of shared cases.
Similar with more cases:
- Cytomegalovirus infection, IBD co-morbidity
- Cytomegaloviral disease
- Infections, IBD-co-morbidities
- Other viral diseases
- Certain infectious and parasitic diseases
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 572 | 309 | 258 |
| Only index persons | 496 | 268 | 228 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.01 | 0.01 |
| Only index persons | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 39.29 | 44.09 | 33.25 |
| Only index persons | 38.68 | 43.17 | 33.39 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 94 | 60 | 34 |
| Unadjusted period prevalence (%) | 0.02 | 0.02 | 0.01 |
| Median age at first event (years) | 44.05 | 46.57 | 39.60 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
No data
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 83
- Matched controls
- 827
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
K77.0*B25.1
ICD-10 Finland
Cytomegaloviral hepatitis
+∞
55.6
47
*
B25.1
ICD-10 Finland
Cytomegaloviral hepatitis
+∞
20.7
19
*
0785B
ICD-9 Finland
Other diseases due to viruses and Chlamydiae, Cytomegaloviral disease[HEPATITIS CYTOMEGALICA]
+∞
17.3
16
*
R50.9
ICD-10 Finland
Fever, unspecified
9.1
15.3
36
64
K75.9
ICD-10 Finland
Inflammatory liver disease, unspecified
97.4
15.2
16
*
L04AA06
ATC
mycophenolic acid; systemic
166.0
13.9
14
*
127
Kela drug reimbursment
Transplant complication
55.4
12.3
14
*
A05AA02
ATC
ursodeoxycholic acid; oral
41.5
11.7
14
*
Z94.4
ICD-10 Finland
Liver transplant status
112.3
9.6
10
*
L04AD01
ATC
ciclosporin; systemic
25.0
8.3
11
5
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
11.2
8.2
15
16
K83.0
ICD-10 Finland
Cholangitis
87.6
7.5
8
*
JJC00
NOMESCO Finland
Allogenic transplantation of liver
+∞
7.4
7
*
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
33.2
7.3
9
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
5.8
7.3
21
46
H02AB04
ATC
methylprednisolone; systemic
4.7
6.9
25
70
TK800
NOMESCO Finland
Hemodialysis
18.7
6.9
10
6
Z94.0
ICD-10 Finland
Kidney transplant status
43.8
6.9
8
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.1
6.5
21
52
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
23
14
21.43
28.12
1.0
1.1
u/ml
476.5
142.8
—
8
9
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
25
19
17.56
27.35
1.3
1.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
23
15
19.98
27.18
1.0
1.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
24
25
12.55
21.51
1.3
1.4
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
16
11
17.32
18.06
1.1
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
15
11
16.04
16.30
1.1
1.1
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
14
14
11.57
12.54
1.8
1.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
25
55
5.83
11.51
1.5
1.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
32
100
4.34
9.59
2.3
1.6
—
—
—
0
0
(3012544) pH of Venous blood
22
55
4.92
8.64
6.4
2.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
13
20
7.38
8.30
1.5
1.3
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
21
53
4.81
8.13
6.5
2.6
kpa
6.0
5.8
0.33
21
53
(3006315) Basophils [#/volume] in Blood
69
396
3.79
7.93
12.7
6.1
e9/l
0.0
0.0
0.42
64
355
(3001604) Monocytes [#/volume] in Blood
69
396
3.79
7.93
12.3
6.0
e9/l
0.6
0.6
0.83
64
352
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
12
9
15.05
7.62
1.1
1.1
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
41
178
3.31
7.30
5.8
4.5
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
51
253
3.22
7.25
6.2
2.9
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
64
363
3.39
7.23
13.1
6.2
%
0.7
0.7
0.31
64
338
(42870588) Differential panel, method unspecified - Blood
51
257
3.15
6.99
13.2
5.8
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
43
198
3.16
6.86
5.1
2.7
e6/l
0.1
0.4
1.29
34
145
(3006504) Eosinophils/100 leukocytes in Blood
64
372
3.26
6.76
13.7
6.1
%
2.4
2.8
0.95
64
349
(3019069) Monocytes/100 leukocytes in Blood
64
373
3.24
6.71
14.5
6.5
%
8.5
8.4
0.10
64
350
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
32
126
3.33
6.59
1.8
1.7
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
29
109
3.40
6.41
5.9
2.7
e6/l
2.8
3.3
0.10
18
62
(3018095) Leukocytes [#/volume] in Urine
50
259
2.99
6.38
6.7
3.5
e6/l
39.8
29.9
0.16
40
186
(3018010) Neutrophils/100 leukocytes in Blood
64
380
3.14
6.37
13.3
5.9
%
55.9
56.3
0.09
64
358
(3002582) Erythrocytes [#/volume] in Urine
45
224
2.94
6.11
5.3
2.9
e6/l
15.9
330.2
0.56
36
173
(36304419) Bacteria [Presence] in Urine
42
204
2.91
5.93
3.6
2.6
—
—
—
0
0
(40758558) Short blood count panel - Blood
42
207
2.86
5.74
12.1
7.6
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
9
7
14.03
5.71
1.1
1.0
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
34
150
2.98
5.68
2.4
2.4
e6/l
4.3
4.5
0.05
29
134
(46235355) HIV 1 and 2 tests - Meaningful Use set
34
150
2.98
5.68
2.0
2.0
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
29
118
3.11
5.56
5.7
2.5
e6/l
0.4
1.0
1.41
18
70
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
58
345
2.78
5.43
12.7
6.5
mmol/l
1.2
1.2
0.86
50
290
(3018418) pH of Serum or Plasma
41
208
2.72
5.21
9.6
3.8
ph
7.4
7.4
—
9
40
(3032080) INR in Blood by Coagulation assay
48
270
2.59
4.88
13.6
6.5
inr
1.0
1.2
—
10
82
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
22
83
3.15
4.73
2.0
1.7
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
15
44
3.87
4.69
4.0
2.5
kpa
5.3
4.8
0.34
15
44
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
10
21
5.21
4.65
2.5
2.0
%
95.0
91.6
—
10
21
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
8
8
10.78
4.61
1.0
1.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
13
36
4.03
4.38
1.6
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
8
9
9.58
4.37
2.0
2.6
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
7
6
12.46
4.35
1.4
1.5
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
9
13
7.52
4.27
1.8
2.1
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
27
121
2.73
4.25
2.0
1.9
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
23
96
2.85
4.12
5.4
2.0
%
24.3
21.3
0.46
18
83
(3021589) Normoblasts [#/volume] in Blood
55
351
2.37
4.01
15.2
9.4
e9/l
0.0
0.0
0.71
48
286
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
20
80
2.91
3.86
1.8
1.6
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
18
68
3.04
3.83
9.1
4.2
%
0.6
0.6
—
7
20
(3021440) Promyelocytes/100 leukocytes in Blood
17
63
3.07
3.73
8.7
4.4
%
0.0
0.1
—
6
17
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
7
9
8.29
3.62
1.4
1.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
12
36
3.67
3.61
2.1
1.8
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
25
117
2.55
3.57
2.1
1.4
titre
888.9
373.3
—
9
24
(3004588) Protein electrophoresis panel - Serum or Plasma
14
48
3.25
3.47
1.6
1.9
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
70
514
2.42
3.46
8.1
4.2
—
—
—
0
0
(4035726)
18
72
2.86
3.46
1.2
1.4
—
—
—
0
0
(3000991) Gas panel - Venous blood
14
49
3.18
3.36
12.4
4.7
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
15
55
3.06
3.34
2.6
2.2
ml/min/173m2
55.6
77.7
—
5
23
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
32
173
2.29
3.32
2.5
2.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
6
7
9.05
3.31
2.0
1.3
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
6
7
9.05
3.31
3.2
1.6
g/l
0.9
0.9
—
6
7
(3021601) Nitrite [Presence] in Urine by Test strip
55
374
2.13
3.18
10.1
4.8
estimate
0.0
0.0
0.00
12
75
(3044640) Blood type and Crossmatch panel - Blood
39
234
2.14
3.10
2.6
2.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
55
379
2.09
3.01
7.3
3.6
estimate
0.0
0.0
0.00
11
72
(3045414) Leukocytes [Presence] in Urine
10
30
3.61
3.00
1.6
1.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
34
197
2.14
2.93
10.4
4.6
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
15
60
2.78
2.87
13.6
2.8
ng/l
107.3
66.5
0.82
15
53
(3037756) Immunofixation for Serum or Plasma
8
18
4.75
2.86
1.3
1.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
10
33
3.27
2.61
1.1
1.5
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
35
213
2.02
2.61
3.5
2.6
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
50
346
1.95
2.57
4.4
2.4
ug/l
111.6
96.4
0.30
45
319
(3016879) Cocaine [Presence] in Urine
11
39
3.06
2.57
1.1
1.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
10
34
3.17
2.49
2.3
4.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
11
41
2.91
2.37
1.1
1.3
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
52
373
1.88
2.33
7.5
3.5
estimate
0.0
0.0
0.00
11
77
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
8
23
3.70
2.33
1.3
1.4
—
—
—
0
0
(3015736) pH of Urine
43
291
1.88
2.30
6.8
3.3
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
7
18
4.11
2.30
1.3
1.8
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
11
42
2.83
2.27
1.1
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
11
42
2.83
2.27
1.1
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
11
42
2.83
2.27
1.1
1.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
17
83
2.28
2.17
2.8
1.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
16
76
2.33
2.17
2.3
3.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
30
187
1.89
2.03
1.6
1.4
g/l
2.4
2.6
0.23
23
116
(3025941) Bacteria identified in Stool by Culture
11
45
2.64
2.01
1.7
1.3
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
5
11
4.73
1.96
1.0
1.1
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
89
804
3.01
1.95
29.8
12.8
mg/l
19.8
21.8
0.28
80
609
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
7
22
3.35
1.92
1.7
2.3
g/l
0.0
0.0
—
7
22
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
7
22
3.35
1.92
1.7
2.3
g/l
0.0
0.0
—
7
22
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
8
28
3.03
1.91
1.7
2.1
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
15
74
2.22
1.87
2.1
1.9
nmol/l
361.6
387.4
0.17
15
68
(3011397) Hemoglobin [Presence] in Urine by Test strip
26
161
1.85
1.77
6.3
3.6
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
7
24
3.07
1.76
1.7
2.2
g/l
0.0
0.6
—
7
24
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
7
24
3.07
1.76
1.7
2.3
g/l
0.0
0.0
—
7
24
(3052851) Hemolysis interference index of Serum or Plasma
6
19
3.30
1.69
3.2
3.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
7
25
2.94
1.68
1.6
2.0
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
15
78
2.10
1.65
3.2
2.3
u/l
34.5
28.9
0.43
15
62
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
8
32
2.64
1.64
4.0
1.3
g/l
0.2
0.2
—
8
32
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
8
32
2.64
1.64
2.5
4.3
mmol/l
23.3
25.4
—
8
32
(3027273) Bicarbonate [Moles/volume] in Venous blood
7
26
2.82
1.61
3.0
2.8
mmol/l
25.9
25.4
—
7
26
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
26
2.82
1.61
1.3
1.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
48
364
1.65
1.58
3.7
3.8
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
8
33
2.55
1.58
4.0
1.3
g/l
1.1
1.2
—
8
33
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
8
33
2.55
1.58
4.1
1.6
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
26
171
1.72
1.44
2.4
1.9
mg/l
2.8
2.8
0.02
21
151
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
67
561
1.68
1.43
3.7
3.2
—
—
—
0
0
(4034850)
5
17
3.05
1.37
28.2
14.9
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
15
84
1.93
1.36
1.7
1.7
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
9
43
2.21
1.34
3.0
1.3
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
11
55
2.13
1.33
5.5
4.7
mmol/l
1.2
1.2
0.20
11
50
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
25
167
1.68
1.30
2.0
1.8
mg/l
1.2
0.8
0.28
19
135
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
22
142
1.72
1.29
1.6
1.5
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
6
25
2.49
1.26
1.3
2.6
%
0.7
0.7
—
6
25
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
6
26
2.39
1.20
1.3
2.6
%
0.8
1.0
—
6
26
(3029937) Albumin [Presence] in Urine by Test strip
27
191
1.58
1.12
6.8
4.1
estimate
0.0
0.0
0.00
12
74
(3014007) Fractional oxyhemoglobin in Arterial blood
7
32
2.28
1.10
8.7
7.3
%
94.3
95.3
—
7
32
(3019225) pH of Specimen
12
67
1.91
1.10
5.1
5.7
—
—
—
0
0
(3000492) Spirometry study
13
76
1.82
1.05
1.4
1.5
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
9
48
1.97
1.04
3.3
1.6
—
—
—
0
0
(3002256) Pathology report gross observation
16
101
1.70
1.01
1.6
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
25
178
1.55
1.00
1.5
1.6
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
14
89
1.67
0.87
1.5
1.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
5
97
0.49
0.83
1.6
1.7
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
5
23
2.24
0.77
1.6
1.5
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
5
23
2.24
0.77
3.0
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
25
321
0.70
0.76
3.6
2.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
9
56
1.67
0.75
6.7
3.6
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
5
25
2.05
0.74
4.2
3.3
%
64.6
55.3
—
5
25
(3011288) Drugs identified in Urine by Screen method
5
25
2.05
0.74
2.0
1.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
5
25
2.05
0.74
1.2
1.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
36
292
1.38
0.73
1.7
2.0
pmol/l
111.4
98.2
0.71
23
144
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
36
292
1.38
0.73
7.6
3.6
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
5
26
1.97
0.72
2.4
1.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
5
26
1.97
0.72
2.4
1.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
5
26
1.97
0.72
2.4
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
29
229
1.39
0.68
1.5
1.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
7
43
1.68
0.68
2.4
4.0
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
28
220
1.39
0.68
2.0
1.7
mmol/l
1.3
1.4
0.23
28
188
(3019309) Folate [Moles/volume] in Red Blood Cells
18
131
1.46
0.65
1.6
1.6
nmol/l
1526.2
1195.1
0.44
13
98
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
5
29
1.76
0.64
10.6
6.0
—
—
—
0
0
(3013512) EKG study
27
214
1.37
0.62
4.2
3.7
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
16
115
1.47
0.61
2.8
2.0
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
20
0.00
0.61
0.0
1.7
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
21
0.00
0.61
0.0
2.2
—
17.9
—
0
21
(3022621) pH of Urine by Test strip
8
53
1.56
0.60
1.8
2.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
28
225
1.35
0.59
7.6
3.2
—
—
—
0
0
(4094501)
0
23
0.00
0.59
0.0
1.0
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
6
36
1.71
0.58
13.3
2.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
9
59
1.58
0.57
1.3
1.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
80
750
1.45
0.57
23.9
12.0
ml/min/173m2
79.0
85.8
1.37
72
601
(40761536) Microorganisms panel - Urine sediment
9
61
1.53
0.56
6.7
3.7
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
8
57
1.44
0.43
1.6
1.2
—
28.5
—
0
6
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
5
32
1.59
0.43
2.0
2.4
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
77
727
1.33
0.43
4.9
5.0
mmol/mol
37.1
39.3
2.47
70
690
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
6
42
1.46
0.36
4.5
1.8
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
6
88
0.66
0.35
1.8
1.6
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
7
100
0.68
0.32
1.7
1.8
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
7
51
1.40
0.32
1.0
1.3
u/ml
122.6
611.4
—
7
46
(3000494) Fungus identified in Specimen by Culture
12
94
1.32
0.30
1.9
1.4
—
—
—
0
0
(4010399)
8
61
1.34
0.29
1.4
1.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
21
181
1.21
0.25
5.2
3.1
mg/l
132.0
44.7
—
10
110
(3013139) Helicobacter pylori Ag [Presence] in Stool
5
37
1.37
0.24
1.2
1.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
87
847
1.36
0.23
20.9
11.7
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
22
192
1.19
0.23
7.5
4.0
mg/mmol
16.8
7.2
0.64
13
111
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
11
0.00
0.21
0.0
5.0
—
107.4
—
0
11
(3042631) Mycobacterium sp identified in Specimen
0
11
0.00
0.21
0.0
5.3
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
10
0.00
0.21
0.0
1.0
—
35.2
—
0
5
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
262.8
—
0
5
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
482.2
—
0
5
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
9
111
0.79
0.21
1.8
2.0
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
12
99
1.24
0.21
1.5
1.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
58
609
0.88
0.20
4.0
4.2
pmol/l
14.7
14.7
0.03
53
554
(3039443) Prostate specific Ag panel - Serum or Plasma
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
6
50
1.21
0.20
4.7
2.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
6
51
1.19
0.20
2.8
1.7
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
12
140
0.84
0.16
5.4
3.8
%
27.2
22.3
—
6
63
(3022145) Colonoscopy Study observation
9
80
1.14
0.15
2.6
1.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
18
163
1.13
0.12
1.4
1.3
iu/ml
22.1
30.9
—
9
59
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
71
727
0.90
0.10
4.5
4.8
mu/l
1.7
1.8
0.81
66
664
(3017732) Neutrophils [#/volume] in Blood
5
63
0.78
0.08
1.4
3.5
e9/l
4.5
4.1
—
5
55
(40768804) Tissue Pathology biopsy report
33
346
0.93
0.08
2.2
1.9
—
—
—
0
0
(3044889) 12 lead EKG panel
52
533
0.95
0.05
3.3
3.6
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
20
189
1.07
0.05
1.5
1.2
u/ml
0.6
0.7
—
6
53
(3009542) Hematocrit [Volume Fraction] of Blood
77
762
1.06
0.02
28.3
13.0
%
38.2
40.6
1.59
67
594
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
27
276
0.97
0.00
4.1
3.5
ng/l
36.9
27.6
0.16
20
170
(21494755) Public health laboratory ask at order entry panel
10
103
0.97
0.00
1.3
1.3
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
30.4
—
0
5
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
8
88
0.90
0.00
2.5
4.4
ug/l
5.0
58.7
—
8
71
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
14.5
—
0
5
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
0.3
—
0
6
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
21.3
—
0
8
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
9
92
0.98
0.00
24.9
6.8
—
—
—
0
0
(4024509)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
7.3
—
0.6
—
0
9
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
13.0
—
741.3
—
0
9
(3017569) Oxygen content in Arterial blood
0
5
0.00
0.00
0.0
14.2
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
23.9
—
1376.4
—
0
9
(3019420) Tryptase [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
7.9
—
0
6
(3029075) Extractable nuclear Ab panel - Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.5
—
125.2
—
0
6
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint CMV_HEPATITIS and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have CMV_HEPATITIS.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: CMV_HEPATITIS – Cytomegaloviral hepatitis
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data